---
title: "NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines"
ocid: "ocds-h6vhtk-058241"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058241"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-058241.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-058241.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")"
published: "2026-01-06"
---

# NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")  
Current stage: Award  
OCID: ocds-h6vhtk-058241

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058241)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-058241.json)

## Summary

NHS National Services Scotland, commonly referred to as The Common Services Agency, facilitated a public procurement process for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. This framework agreement, valued at approximately £52,999,636, is divided into twenty categories, or lots, each covering specific pharmaceutical products. The procurement process followed an open procedure under legal framework 32014L0024 and is currently in the award stage. Contracts were signed on 12 December 2025 and will span a period of 720 days, with the possibility of a 24-month extension. Key suppliers include Aguettant Ltd, Martindale Pharma, and Accord Healthcare Ltd, among others, spread across regions in the UK, primarily serving entities established under the National Health Services (Scotland) Act 1978.

This tender presents a significant opportunity for businesses involved in pharmaceutical production and distribution to expand their operations within the UK healthcare sector. SMEs that can meet the stringent quality assurance criteria and possess the required certifications, such as BS EN ISO 9001, are particularly well-suited to participate. Due to the framework agreement's focus on community benefits, businesses that can demonstrate strong engagements with community benefit programmes and present thorough environmental management plans will have a competitive advantage. The variety in lots within the framework allows for diverse participation, ranging from single-supplier awards to multi-supplier frameworks, offering flexibility and potential for growth to various business scales.

## Notice

This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

### Lot Information

Lot 1 - Baclofen Intrathecal Injections

Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 2 - Oxycodone Injections

The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 3 - Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection

The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 4 - Oxycodone Hydrochloride Prolonged Release Tablets

The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 5 - Buprenorphine Patches

The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 6 - Fentanyl Tablets (Sublingual)

The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 7 - Fentanyl Sf Tablet (Buccal)

Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority has not awarded this Lot.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 8 - Fentanyl Transdermal Patch

Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 9 - Hydromorphone

Supply of Hydromorphone Capsules and Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot to a single Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 10 - Lidocaine Chlorhexidine Gel

Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)

Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)

The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 13 - Morphine Sulfate Modified-Release Tablet

The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 14 - Oxycodone Hydrochloride Capsules

The Supply of Oxycodone Hydrochloride Capsules to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 15 - Propofol Injection

The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 16 - Tramadol Hydrochloride Modified Release Tablets

The Supply of Tramadol Hydrochloride Modified Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 17 - Oxycodone Oral Solution

The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 18 - Levobupivacaine (As Hydrochloride) Solution For Infusion

The Supply of Levobupivacaine (As Hydrochloride) Solution For Infusion to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 19 - Supply to NHSS Pharmaceuticals "Specials" Service

The supply of a range of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to the NHSS Pharmaceuticals "Specials" Service. The Authority has awarded each product line within this Lot to a single Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 20 - Levobupivacaine Solution for injection ampoules (unwrapped)

Supply of Levobupivacaine solution for injection ampoules (unwrapped) all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 21 - All other Analgesics and Anaesthetic Generic Medicines

Supply of all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/000677-2026 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 6 Jan 2026 |
| Submission deadline | 8 Sep 2025 |
| Future notice date | Not specified |
| Award date | 12 Dec 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £52,999,636 |
| Lots value | £52,999,636 |
| Awards value | Not specified |
| Contracts value | £22,471,323 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active, Unsuccessful |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 45 |
| Supplier names | ACCORD HEALTHCARE; ACCORD-UK; AGUETTANT; ARCADIA PHARMA LIMITED T/A ARCADIA MEDICAL; ASPEN HEALTHCARE SOLUTIONS; ASPIRE PHARMA; B BRAUN MEDICAL; BAXTER HEALTHCARE; BOWMED IBISQUS; CHIESI; CLINIMED; DRUGSRUS; ENNOGEN HEALTHCARE INTERNATIONAL; FRESENIUS KABI; GEROT LANNACH; GLAXOSMITHKLINE; GLENMARK PHARMACEUTICALS EUROPE; HAMELN PHARMA; HIKMA PHARMACEUTICALS; INTRAPHARM LABORATORIES; KENT PHARMACEUTICALS; KYOWA KIRIN INTERNATIONAL NEWCO; MARTINDALE PHARMA; MEDREICH; MERCURY PHARMACEUTICALS; MORNINGSIDE PHARMACEUTICALS; NAPP PHARMACEUTICALS; NEON HEALTHCARE; NOVUMGEN; OPTIMUM MEDICAL; PANPHARMA; PFIZER; PHOENIX LABS; PIRAMAL CRITICAL CARE; QDEM PHARMACEUTICALS; RIDGE PHARMA; SANDOZ; STADA UK - THORNTON & ROSS; SVP PHARMA; TEVA; TORBAY PHARMA; TYPHARM; VIATRIS UK HEALTHCARE; WOCKHARDT; ZENTIVA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 6 Jan 2026 at 13:39 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/000677-2026
- 6 Aug 2025 at 10:06 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/046428-2025

## Notice URLs

- http://www.nhsscotlandprocurement.scot.nhs.uk/
- http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000796255
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html
- https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058241. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-058241.json.
